FISH to visualize genetic abnormalities characteristic of pancreatic cancer

Name: FISH to visualize genetic abnormalities characteristic of pancreatic cancer
Uploaded: 2012-12-14T00:00:00+00:00
Description: Dr. Gordon DeWald, professor emeritus in laboratory medicine and laboratory genetics at Mayo Clinic, provides an overview of his study on the use of fluorescence in situ hybridization (FISH).

Dr. Gordon DeWald, professor emeritus in laboratory medicine and laboratory genetics at Mayo Clinic, provides an overview of his study on the use of fluorescence in situ hybridization (FISH) to visualize genetic abnormalities characteristic of pancreatic cancer. Article available at: http://tinyurl.com/cwbzue8

Published

December 14, 2012

Created by

Related Videos

Mayo Clinic researcher on factors to improve breast cancer risk prediction

Mayo Clinic researcher Fergus J. Couch, Ph.D., discusses a study show that combined 77 common genetic variants into a single risk factor that can be used to improve the identification of women with an elevated risk of breast cancer.

Methylated DNA markers and whole-body cancer screening

John B. Kisiel, M.D., a gastroenterologist at Mayo Clinic's campus in Rochester, Minnesota, discusses a study that identified the source of cancer in patients' gastrointestinal tracts by analyzing DNA markers from tumors.

Researchers locate master cutoff switch for cancer-causing HER2 protein

Herceptin has been touted as a wonder drug for women with HER2-positive breast cancer, an aggressive form of the disease that is fueled by excess production of the HER2 protein.

Ibrutinib with chemotherapy offers longer life to people with B-Cell cancers

Researchers found that a combination of ibrutinib and chemotherapy reduced the risk of death or cancer progression by 80 percent in people with previously treated chronic lymphocytic leukemia.

Mayo Clinic researchers find 2 oncogenes join to drive lung squamous cell carcinoma

Alan P. Fields, Ph.D., and Dr. Monica Flynn Jacoby, professor of cancer studies at Mayo Clinic's campus in Florida, talk about the publication of his team's latest discovery.

Grand Rounds — Breast Cancer Genome-Guided Therapy Study: Next-Generation Sequencing for the Management of Women With High-Risk Breast Cancer

Judy C. Boughey, M.D., and Matthew P. Goetz, M.D., present Breast Cancer Genome-Guided Therapy Study: Next-Generation Sequencing for the Management of Women With High-Risk Breast Cancer.

Canadian study: Screening mammograms do not cut breast cancer deaths

A study published today in the journal BMJ says annual screening mammograms in women ages 40 to 59 do not reduce deaths from breast cancer any better than a physical examination or usual care.

Grand Rounds: Targeting Polarity Pathways for Cancer Treatment

Panagiotis Z. Anastasiadis, Ph.D., presents Targeting Polarity Pathways for Cancer Treatment.

Precursor of multiple myeloma more common in blacks than whites, Mayo study finds

Blacks may be twice as likely as whites to develop multiple myeloma because they are also more likely to have a precursor condition known as monoclonal gammopathy of undetermined significance.

Medical Professional Video Center

Search Video Center